Challenges in Translational Cancer Research
Author Information
Author(s): Linder Stig, Shoshan Maria C
Primary Institution: Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institute and Hospital
Hypothesis
Is translational research compatible with preclinical publication strategies?
Conclusion
The study argues that many factors hinder the effective translation of cancer research from the lab to clinical practice.
Supporting Evidence
- Translational cancer research often fails due to the use of unrealistic models and conditions.
- Many preclinical studies use sensitive cell lines that do not accurately represent human tumors.
- High drug concentrations used in studies may not be applicable to real-world clinical settings.
Takeaway
Scientists are trying to turn lab discoveries into real cancer treatments, but they often use methods that don't work well in real patients.
Potential Biases
There is a risk of aggressive interpretation of data that may not reflect clinical realities.
Limitations
The article discusses the limitations of using sensitive cell lines and unrealistic drug concentrations in preclinical studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website